705 related articles for article (PubMed ID: 30859281)
1. Convolutional neural network to predict the local recurrence of giant cell tumor of bone after curettage based on pre-surgery magnetic resonance images.
He Y; Guo J; Ding X; van Ooijen PMA; Zhang Y; Chen A; Oudkerk M; Xie X
Eur Radiol; 2019 Oct; 29(10):5441-5451. PubMed ID: 30859281
[TBL] [Abstract][Full Text] [Related]
2. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint.
Duan DK; Zhang GC; Sun BJ; Ma TX; Zhao M
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5039-5052. PubMed ID: 37318478
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Preoperative CT and MR Imaging Findings in the Prediction of Postoperative Recurrence of Spinal Giant Cell Tumor of Bone.
Wang QZ; Zhang EL; Xing XY; Su MY; Lang N
Orthop Surg; 2021 Dec; 13(8):2405-2416. PubMed ID: 34841660
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance feature of "paintbrush borders" sign as a novel way to predict recurrence of giant cell tumor of bone after curettage: a pilot study.
He Y; Wang J; Zhang J; Du L; Lu Y; Xu J; Yuan F; Tan Y; Ding X
J Int Med Res; 2018 Feb; 46(2):710-722. PubMed ID: 29239274
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
[TBL] [Abstract][Full Text] [Related]
6. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
7. A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint.
He Y; Wang J; Zhang J; Yuan F; Ding X
Radiol Med; 2017 Jul; 122(7):546-555. PubMed ID: 28271359
[TBL] [Abstract][Full Text] [Related]
8. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
Perrin DL; Visgauss JD; Wilson DA; Griffin AM; Abdul Razak AR; Ferguson PC; Wunder JS
Bone Joint J; 2021 Jan; 103-B(1):184-191. PubMed ID: 33380180
[TBL] [Abstract][Full Text] [Related]
9. Computerised tomography features of giant cell tumour of the knee are associated with local recurrence after extended curettage.
Zhou L; Zhu H; Lin S; Jin H; Zhang Z; Dong Y; Yang Q; Zhang C; Yuan T
Int Orthop; 2022 Feb; 46(2):381-390. PubMed ID: 34783889
[TBL] [Abstract][Full Text] [Related]
10. Recurrence in giant cell tumour of bone: imaging features and risk factors.
Wang CS; Lou JH; Liao JS; Ding XY; Du LJ; Lu Y; Yan L; Chen KM
Radiol Med; 2013 Apr; 118(3):456-64. PubMed ID: 22872452
[TBL] [Abstract][Full Text] [Related]
11. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
Sano K; Suehara Y; Okubo T; Sasa K; Kurihara T; Akaike K; Kubota D; Torigoe T; Hasegawa N; Ishii M; Nakamura Y; Kim Y; Takagi T; Kaneko K; Hayashi T; Saito T
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020929786. PubMed ID: 32539628
[TBL] [Abstract][Full Text] [Related]
12. Giant cell tumor of bone with secondary aneurysmal bone cyst does not have a higher risk of local recurrence.
Tsukamoto S; Aiba H; Righi A; Nitta Y; Traversari M; Mavrogenis AF; Honoki K; Tanaka Y; Donati DM; Errani C
J Surg Oncol; 2023 Aug; 128(2):350-358. PubMed ID: 37053028
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
[TBL] [Abstract][Full Text] [Related]
14. MRI assessment of the bone adjacent to giant cell tumours and its association with local recurrence after intralesional curettage.
He Y; Wang J; Du L; Yuan F; Ding X; Wang H
Clin Radiol; 2018 Nov; 73(11):984.e19-984.e28. PubMed ID: 30228005
[TBL] [Abstract][Full Text] [Related]
15. Curettage as first surgery for bone giant cell tumor : adequate surgery is more important than oncology training or surgical management by high volume specialized teams.
Tsukamoto S; Mavrogenis AF; Tanzi P; Leone G; Akahane M; Tanaka Y; Errani C
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):3-9. PubMed ID: 31520122
[TBL] [Abstract][Full Text] [Related]
16. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
[TBL] [Abstract][Full Text] [Related]
17. Treatment options for recurrent giant cell tumors of bone.
Balke M; Ahrens H; Streitbuerger A; Koehler G; Winkelmann W; Gosheger G; Hardes J
J Cancer Res Clin Oncol; 2009 Jan; 135(1):149-58. PubMed ID: 18521629
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of MRI and Pathological Features of Giant Cell Tumor of Bone Boundary.
Chen L; Shi XL; Zhou ZM; Qin LD; Liu XH; Jiang L; Zhang QJ; Ding XY
Orthop Surg; 2019 Aug; 11(4):628-634. PubMed ID: 31422584
[TBL] [Abstract][Full Text] [Related]
19. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
20. In-depth analysis of local recurrence of giant cell tumour of bone with soft tissue extension after intralesional curettage.
Chen L; Ding XY; Wang CS; Si MJ; Du LJ; Zhang WB; Lu Y
Radiol Med; 2014 Nov; 119(11):861-70. PubMed ID: 24604549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
